Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours

British Journal of Cancer

Volumn 95, Issue 1, 2006, Pages 49-55

  Uccini, S ^a   Colarossi, C ^a   Scarpino, S ^a   Boldrini, R ^b   Natali, P G ^c   Nicotra, M R ^d   Perla, F M ^a   Mannarino, O ^a   Altavista, P ^e   Boglino, C ^b   Cappelli, C A ^a   Cozzi, D ^a   Donfrancesco, A ^b   Kokai, G ^f   Losty, P D ^f   McDowell, H P ^f   Dominici, C ^a,b,g  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d CNR   (Italy)

^e ENEA C R CASACCIA   (Italy)

^f ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Caspases; Mitosis karyorrhexis index (MKI); Neuroblastoma; p53; Tumour necrosis factor related apoptosis inducing ligand (TRAIL)

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1;

ADOLESCENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MITOSIS; MITOSIS KARYORRHEXIS INDEX; NERVOUS SYSTEM TUMOR; NEUROBLAST; NEUROBLASTIC TUMOR; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADOLESCENT; APOPTOSIS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MITOTIC INDEX; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745561038     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603212     Document Type: Article

References (40)

1. Alaminos M, Mora J, Cheung NK, Smith A, Qin J, Chen L, Gerald WL (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res 63: 4538-4546
2. Ambros IM, Hata J, Joshi VV, Roald B, Dehner LP, Tuchler H, Potschger U, Shimada H (2002) Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups. Cancer 94: 1574-1583
3. Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255-260
4. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216
5. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Carlsen V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Tsuchida Y, Philip T, Roald B, Voute PA (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477
6. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G (1993) Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 143: 1543-1550
7. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656
8. Cox DR (1972) Regression models and life tables. J R Stat Soc 334: 187-220
9. De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P (2003) Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-operative Group for Neuroblastoma. J Clin Oncol 21: 1592-1601
10. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, Castle VP (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 54: 3253-3259
11. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55: 2576-2582
12. Dominici C, Negroni A, Romeo A, Castello MA, Clerico A, Scopinaro M, Mauro F, Raschellà G (1989) Association of near-diploid DNA content and N-myc amplification in neuroblastomas. Clin Exp Metast 7: 201-211
13. Evan G, Littlewood T (1998) A matter of life and cell death. Science 281: 1317-1322
14. Evans AE, Gerson J, Schnaufer L (1976) Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr 44: 49-54
15. Fulda S, Debatin KM (2003) Apoptosis pathways in neuroblastoma therapy. Cancer Lett 197: 131-135
16. Gestblom C, Hoehner JC, Pahlman S (1995) Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer 31A: 458-463
17. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60: 4315-4319
18. Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, Takahashi A, Kiroiwa M (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30: 805-808
19. Ikegaki N, Katsumata M, Tsujimoto Y, Nakagawara A, Brodeur GM (1995) Relationship between bcl-2 and myc gene expression in human neuroblastoma. Cancer Lett 91: 161-168
20. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
21. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 146: 3-15
22. Moll UM, LaQuaglia M, Benard J, Riou G (1995) Wilde-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92: 4407-4411
23. Muhlethaler-Mottet A, Balmas K, Auderset K, Joseph JM, Gross N (2003) Restoration of TRAIL-induced apoptosis in a caspase-8-deficient neuroblastoma cell line by stable re-expression of caspase-8. Ann N Y Acad Sci 1010: 195-199
24. Nakagawara A (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169: 107-114
25. Nakagawara A, Ohira M (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204: 213-224
26. Nikolaev AY, Li M, Puskas N, Qin J, Gu W (2003) Parc: a cytoplasmic anchor for p53. Cell 112: 29-40
27. Ohira M, Morohashi A, Inuzuka H, Shishikura T, Kawamoto T, Kageyama H, Nakamura Y, Isogai E, Takayasu H, Sakiyama S, Suzuki Y, Sugano S, Goto T, Sato S, Nakagawara A (2003) Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favourable and unfavourable subsets. Oncogene 22: 5525-5536
28. Özören N, El-Deiry WS (2003) Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol 13: 135-147
29. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187: 112-126
30. Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC (1995) Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87: 1470-1476
31. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999a) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86: 349-363
32. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP (1999b) The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86: 364-372
33. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK (2001) International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92: 2451-2461
34. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, Lahti JM, Cheresh DA (2006) Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439: 95-99
35. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529-535
36. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
37. Tweddle DA, Pearson AD, Haber M, Norris MD, Xue C, Flemming C, Lunec J (2003) The p53 pathway and its inactivation in neuroblastoma. Cancer Lett 197: 93-98
38. van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG, Versteeg R (2002) Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res 62: 2157-2161
39. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pellettier J, Gros P (1993) Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53: 5269-5273
40. Wu GS, Burns TF, McDonald 3rd ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El-Deiry WS (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143